Ory TL - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells.

Xia W, Gerard CM, Liu L, Baudson NM, Ory TL, Spector NL. Xia W, et al. Among authors: ory tl. Oncogene. 2005 Sep 15;24(41):6213-21. doi: 10.1038/sj.onc.1208774. Oncogene. 2005. PMID: 16091755

Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.

Gérard C, Baudson N, Ory T, Louahed J. Gérard C, et al. PLoS One. 2014 May 15;9(5):e94883. doi: 10.1371/journal.pone.0094883. eCollection 2014. PLoS One. 2014. PMID: 24830315 Free PMC article.

A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors.

Gérard C, Baudson N, Ory T, Segal L, Louahed J. Gérard C, et al. J Immunother. 2015 Oct;38(8):311-20. doi: 10.1097/CJI.0000000000000095. J Immunother. 2015. PMID: 26325375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters